Background Human papillomavirus (HPV) infection is a major risk factor for the development
of nearly all cases of cervical cancer worldwide. The presence of HPV DNA in cases of …

Objective ASCCP cervical cancer screening guidelines recommend triaging high-risk
human papillomavirus (hrHPV) positive women with cytology and genotyping, but cytology is …

Background Persistent high-risk human papillomavirus (HPV) infection is correlated with an
increased risk of developing intraepithelial lesion or malignancy (NILM). The aims of the …

Evidence for the clinical utility of human papillomavirus (HPV) DNA testing has increased
over the years and has now become very convincing. Some specific uses of HPV detection …

As cervical cancer screening shifts from cytology to human papillomavirus (HPV) testing, a
major question is the clinical value of identifying individual HPV types. We aimed to validate …

The clinical utility of HPV 16 and 18 viral loads remains debated. The aim of this study was
to assess the clinical significance of HPV 16 and 18 viral load and to determine a cut‐off for …

Methods: One hundred and thirty two pretreatment cervical tumour biopsies were selected
from patients undergoing radiotherapy alone (n= 63) or concomitant chemo-radiation (n …

It has been recognized that human papillomavirus infection is the major causal factor for
high‐grade cervical lesions. The aim of the study was to evaluate the relationship between …

Human papilloma virus (HPV) infections, which are common, produce epithelial lesions of
the nongenital and genital skin and mucous membranes. Although most infections are …